SynthesisFrontiers in pharmacology2022

Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review.

Meiyu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.